Qube Research & Technologies Ltd
Position in AKBA — Akebia Therapeutics, Inc.
CIK 1729829
LONDON, X0
Position in AKBA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,329,348
-$1,485,786 QoQ
Shares Held
2,395,215
-19.9% QoQ
Ownership
0.864%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AKBA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Qube Research & Technologies Ltd holds $391,222,630 across 21 Drug Manufacturers - Specialty & Generic names. AKBA ranks #15 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
9,666,750 | $130,597,792 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
123,441 | $73,198,044 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
686,853 | $33,071,971 | |
| 4 | SUPN |
Supernus Pharmaceuticals, Inc.
|
498,198 | $25,751,854 | |
| 5 | XERS |
Xeris Biopharma Holdings, Inc.
|
4,114,425 | $23,863,665 | |
| 6 | COLL |
Collegium Pharmaceutical, Inc
|
621,935 | $20,567,390 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
210,130 | $16,158,997 | |
| 8 | INDV |
Indivior Pharmaceuticals, Inc.
|
429,363 | $13,086,984 |
All Filings in AKBA
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,329,348 | 2,395,215 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,815,134 | 2,990,767 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $8,752,882 | 3,206,184 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,240,940 | 1,714,544 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,051,091 | 1,068,277 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,263,582 | 1,191,359 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,747,322 | 1,323,729 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,779,507 | 1,744,616 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,140,697 | 2,262,676 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $318,894 | 257,173 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $138,414 | 121,416 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $399,186 | 436,269 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $8,571 | 14,855 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $66,282 | 209,755 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $211,227 | 598,379 | Shares | Sole | 2022-08-15 | |
| 2021-06-30 | $157,527 | 41,564 | Shares | Sole | 2021-08-13 | |
| 2020-06-30 | $293,545 | 21,616 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||